PHARMACEUTICAL IMPURITY STANDARD
NO.1 SUPPLIER & MANUFACTURER
Run for science and technology, promote human health
PHARMACEUTICAL IMPURITY STANDARD NO.1 SUPPLIER & MANUFACTURER
Run for science and technology, promote human health
Location: Home > NEWS & INSIGHTS

Event Recap | CPI 2025 Chengdu Chapter Concludes – Until We Meet Again!

Time:2025-03-25


5c2e96a660e5f2c542c395f49fe654f9_640_wx_fmt=png&from=appmsg&wx_&wx_&tp=webp&wxfrom=5&wx_lazy=1.png


March 20-21, 2025 – The two-day CPI 2025 China Pharmaceutical Industry Summit came to a successful close at Crowne Plaza Chengdu Wuhou.
At this premier industry gathering, Shenzhen ChemStrong Scientific Co.,Ltd., made its mark at Booth A30。


image.png


Live from the Scene
The venue was bustling with activity, and the Zhenqiang professional team warmly welcomed every client at their booth, listening attentively and responding proactively, dedicated to providing excellent service to each and every customer.


image.png

image.png


 A Perfect Conclusion

image.png


Back

CONTACT US

Service hotline: +86 0755-66853366
Marketing Department: +86 136 7004 6396 (WeChat)
Email: sales@chem-strong.com
Office address: Room 1201, Jiaye Plaza, No. 2055, Bixin Road, Longgang District, Shenzhen

*All of our products are for R&D use only, and cannot be used in human or animal clinical use

FOLLOW US

ChemStrong

QCS R&D Center

Copyright 2006-2024 © ShenZhen ChemStrong Scientific Co., Ltd. 备案号:粤ICP备19155981号 Shenzhen Municipal Administration for Market Regulation Enterprise Identity Disclosure

CONTACT US

Service hotline: +86 0755-66853366
Marketing Department: +86 136 7004 6396 (WeChat)
Email: sales@chem-strong.com
Office address: Room 1201, Jiaye Plaza, No. 2055, Bixin Road, Longgang District, Shenzhen
*All of our products are for R&D use only, and cannot be used in human or animal clinical use

FOLLOW US

ChemStrong

QCS R&D Center

Copyright 2006-2024 © ShenZhen ChemStrong Scientific Co., Ltd. 备案号:粤ICP备19155981号 Shenzhen Municipal Administration for Market Regulation Enterprise Identity Disclosure